| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7507771 | Drug and Alcohol Dependence | 2013 | 8 Pages |
Abstract
A strategy of on-site rapid HIV testing offer with information only in substance abuse treatment programs increases life expectancy at a cost-effectiveness ratio <$100,000/QALY. Policymakers and substance abuse treatment leaders should seek funding to implement on-site rapid HIV testing in substance abuse treatment programs for those not recently tested.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Bruce R. Schackman, Lisa R. Metsch, Grant N. Colfax, Jared A. Leff, Angela Wong, Callie A. Scott, Daniel J. Feaster, Lauren Gooden, Tim Matheson, Louise F. Haynes, A. David Paltiel, Rochelle P. Walensky,